Mesa Laboratories
MLAB
Mesa Laboratories (MLAB) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Equal-Weight | $110.00 from $94.00 | Aug 14, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $94.00 from $83.00 | Feb 4, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $83.00 from $75.00 | Dec 15, 2025 |
| Wells Fargo | Upgraded | Underweight → Equal-Weight | $67.00 from $100.00 | Aug 8, 2025 |
| Wells Fargo | Maintained | Underweight | $100.00 from $120.00 | May 30, 2025 |
| Evercore ISI Group | Maintained | Outperform | $160.00 from $120.00 | Oct 1, 2024 |
| Wells Fargo | Initiated Coverage | Underweight | $120.00 | Aug 27, 2024 |
| Evercore ISI Group | Maintained | Outperform | $120.00 from $106.00 | Aug 6, 2024 |
| Evercore ISI Group | Maintained | Outperform | $106.00 from $120.00 | Jul 2, 2024 |
| Evercore ISI Group | Maintained | Outperform | $130.00 from $124.00 | Apr 4, 2024 |
| Evercore ISI Group | Upgraded | In-Line → Outperform | $125.00 from $100.00 | Jan 4, 2024 |
Frequently asked questions
What is the latest analyst rating on MLAB?
On Aug 14, 2026, Wells Fargo maintained Mesa Laboratories at Equal-Weight with a price target of $110.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.